FDA Approves Loracarbef for Treating Certain Infections, Combining it with Rifabutin for TB Treatment

Summary

The US Food and Drug Administration (FDA) has approved Loracarbef, a new antibiotic, to treat certain bacterial infections, and it will be available in capsule and oral suspension forms. Loracarbef will be used in combination with Rifabutin to treat tuberculosis (TB) infections.